SecBot SecBot

NRXP

NRX Pharmaceuticals, Inc.
Nasdaq· Pharmaceutical Preparations· Inc. DE· CIK 0001719406 Biotech & Drug Discovery
$2.15 −0.04 (−1.83%)
Nov 16 4:00 PM ET · prev $2.19
Market cap
$99.5M
Micro cap
Consensus
Buy
91% Buy or better · 11 analysts
Median target
$49.00
+2179% · range $45.00–51.00
1 year
+1.9%
from $2.11 · Nov 17
30 days
−18.3%
from $2.63
52-week range
$1.68–4.62
−53% from high · low Feb 5
Avg volume 20D
1.74M
Oct 30 spike 15.64M
Short interest
10.46M
≈24.0% of shares · +5.2%
Days to cover
4.6
at average volume
Insider net
$0
no open-market trades · 12 mo
New fund stakes
0
Q3 2026 13F · 0 exits
Reddit crowd
50°
Neutral · 1 mention this week
SecBot read BULLISH 8 reports · 90 days
Balance 0 bearish · 4 bullish · 4 neutral oldest → newest, height = score
Avg score ·High conf. 5/8

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.

  • InstitutionsBULLISH

    Q3 2026: 13 added (0 new), 2 trimmed or exited.

  • AnalystsBULLISH

    10 of 11 rate it Buy or better. Every target is above the price.

  • EstimatesFALLING

    Current-quarter EPS estimate −$0.080 → −$0.150 over 90 days. 0 up, 1 down in 30 days.

  • Short sellersSTEADY

    Short interest +5.2% to 10.46M shares. 4.6 days to cover, ≈24.0% of shares.

  • TrendDOWNTREND

    23% below its 50-day average.

  • SocialQUIET

    Crowd 50° (neutral) this week from 1 mention: 0 bullish, 0 bearish. No setup is alerting.

Who's buying

13F· Q3 2026
0
new positions
0
exits
FundMoveSharesValue
MARSHALL WACE, LLPDOUBLED995,172$2.9M
COMMONWEALTH EQUITY SERVICES, LLCADD590,768$1.7M
GEODE CAPITAL MANAGEMENT, LLCADD446,457$1.3M
VANGUARD FIDUCIARY TRUST COADD259,798$758.6K
MORGAN STANLEYDOUBLED102,207$298.4K
JANE STREET GROUP, LLCTRIM36,293$106.0K
Vanguard Global Advisers, LLCDOUBLED17,184$50.2K
RENAISSANCE TECHNOLOGIES LLCTRIM12,300$35.9K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

11 analysts
Buy 91% rate it Buy or better
Strong Buy3Buy7Hold1Sell0Strong Sell0
12-month targets · 3 analysts

Price is below the lowest target. Median implies +2179%.Targets as of Nov 17, 2026.

Recent actions
DateFirmActionRating
Nov 11, 2026BTIG
MAINTAIN
MAINTAINBuy
Nov 2, 2026Ascendiant Capital
MAINTAIN
MAINTAINBuy
Oct 1, 2026Ascendiant Capital
MAINTAIN
MAINTAINBuy
Sep 14, 2026BTIG
REITERATE
REITERATEBuy
Aug 25, 2026HC Wainwright & Co.
REITERATE
REITERATEBuy
Aug 18, 2026BTIG
REITERATE
REITERATEBuy

Washington

Corporate Lobbying

14 lobbying filings and 3 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

Insider ledger

Form 4
$0
open-market buys or sells · 12 mo
DateInsiderTypeValue
Jul 28, 2026
ABRAMS MICHAEL S
Chief Financial Officer
Jul 28, 2026
AWARD75,000 sh
Jul 28, 2026
Javitt Jonathan C
CEO and Chairman
Jul 28, 2026
AWARD150,000 sh
Jan 27, 2026
Casper Joseph Michael
Chief Operating Officer
Jan 27, 2026
AWARD100,000 sh

Earnings setup

Estimates
−$0.15
EPS estimate, this quarter
−87%
estimate change, 90 days
0↑ 1↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.15-$0.15–-$0.15+0.0%$1.3M
Next Q-$0.17-$0.17–-$0.17+0.0%$2.6M
Current FY-$0.80-$0.80–-$0.80+0.0%$5.6M
Next FY-$0.35-$0.35–-$0.35+0.0%$77.5M
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.

Short side

FINRA· Oct 30, 2026
10,462,226
shares short
+5.2%
vs prior settlement
4.6
days to cover
≈24.0%
of shares outstanding
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
1 drug tracked · Drug pipeline →
Recent
Reddit Mentions per day, 14 days
Crowd this week 50° Neutral 0 bullish · 0 bearish
Mentions, 7 days 1 1 in posts · 0 in comments
Recent posts
All social signals and their track records

SecBot reports

14 filings · 8 press releases · 7 bullish · 0 bearish · 7 neutral
All NRXP filing & press-release reports (22)